Literature DB >> 33754018

Relieving lipid accumulation through UCP1 suppresses the progression of acute kidney injury by promoting the AMPK/ULK1/autophagy pathway.

Wei Xiong1, Zhiyong Xiong2, Anni Song1, Chuntao Lei1, Chen Ye1, Chun Zhang1.   

Abstract

Rationale: Acute kidney injury (AKI) is a serious clinical emergency with an acute onset, rapid progression, and poor prognosis. Recent evidence suggests that AKI is accompanied by significant metabolic abnormalities, including alterations in lipid metabolism. However, the specific changes in lipids in AKI, and their role and regulation mechanisms are currently unclear.
Methods: Quantitative metabolomics was performed in AKI models to reveal the differences of lipid metabolism-related products. Regulated pathway was detected by western blot, qRT-PCR, immunoblot analysis and immunohistochemistry.
Results: The present study systematically analyzes the changes in lipid composition in AKI for the first time and find that the degree of lipid accumulation was highly correlated with uncoupling protein 1 (UCP1). Importantly, relieving lipid accumulation in AKI by upregulating UCP1 can significantly inhibit the progression of AKI through promoting AMPK/ULK1/autophagy pathway. Conclusions: The present findings suggest that lipid accumulation in AKI is directly regulated by UCP1, which can activate cell autophagy and thus significantly inhibit disease progression. It will provide new ideas and targets for the treatment of AKI. © The author(s).

Entities:  

Keywords:  UCP1; acute kidney injury; autophagy; lipids; metabolic reprogramming

Year:  2021        PMID: 33754018      PMCID: PMC7978316          DOI: 10.7150/thno.56082

Source DB:  PubMed          Journal:  Theranostics        ISSN: 1838-7640            Impact factor:   11.556


  48 in total

Review 1.  Cellular metabolism and disease: what do metabolic outliers teach us?

Authors:  Ralph J DeBerardinis; Craig B Thompson
Journal:  Cell       Date:  2012-03-16       Impact factor: 41.582

Review 2.  Pre-procedural glucose levels and the risk for contrast-induced acute kidney injury in patients undergoing coronary angiography.

Authors:  Joshua M Stolker; Peter A McCullough; Seshu Rao; Silvio E Inzucchi; John A Spertus; Thomas M Maddox; Frederick A Masoudi; Lan Xiao; Mikhail Kosiborod
Journal:  J Am Coll Cardiol       Date:  2010-04-06       Impact factor: 24.094

Review 3.  Browning of White Fat: Novel Insight Into Factors, Mechanisms, and Therapeutics.

Authors:  Nevena Jeremic; Pankaj Chaturvedi; Suresh C Tyagi
Journal:  J Cell Physiol       Date:  2016-06-21       Impact factor: 6.384

4.  Melatonin/PGC1A/UCP1 promotes tumor slimming and represses tumor progression by initiating autophagy and lipid browning.

Authors:  Wen Xiao; Zhiyong Xiong; Wei Xiong; Changfei Yuan; Haibing Xiao; Hailong Ruan; Zhengshuai Song; Cheng Wang; Lin Bao; Qi Cao; Keshan Wang; Gong Cheng; Tianbo Xu; Junwei Tong; Lijie Zhou; Wenjun Hu; Zeyuan Ru; Di Liu; Hongmei Yang; Xiaoping Zhang; Ke Chen
Journal:  J Pineal Res       Date:  2019-09-13       Impact factor: 13.007

Review 5.  Understanding autophagy in cell death control.

Authors:  Francesca Platini; Ricardo Pérez-Tomás; Santiago Ambrosio; Luciana Tessitore
Journal:  Curr Pharm Des       Date:  2010-01       Impact factor: 3.116

Review 6.  Metabolic reprogramming in clear cell renal cell carcinoma.

Authors:  Hiromi I Wettersten; Omran Abu Aboud; Primo N Lara; Robert H Weiss
Journal:  Nat Rev Nephrol       Date:  2017-05-08       Impact factor: 28.314

7.  Ectopic UCP1 Overexpression in White Adipose Tissue Improves Insulin Sensitivity in Lou/C Rats, a Model of Obesity Resistance.

Authors:  Anne-Laure Poher; Christelle Veyrat-Durebex; Jordi Altirriba; Xavier Montet; Didier J Colin; Aurélie Caillon; Jacqueline Lyautey; Françoise Rohner-Jeanrenaud
Journal:  Diabetes       Date:  2015-07-29       Impact factor: 9.461

Review 8.  Acute Kidney Injury.

Authors:  Anna Zuk; Joseph V Bonventre
Journal:  Annu Rev Med       Date:  2016       Impact factor: 13.739

9.  UCP1-independent signaling involving SERCA2b-mediated calcium cycling regulates beige fat thermogenesis and systemic glucose homeostasis.

Authors:  Kenji Ikeda; Qianqian Kang; Takeshi Yoneshiro; Joao Paulo Camporez; Hiroko Maki; Mayu Homma; Kosaku Shinoda; Yong Chen; Xiaodan Lu; Pema Maretich; Kazuki Tajima; Kolapo M Ajuwon; Tomoyoshi Soga; Shingo Kajimura
Journal:  Nat Med       Date:  2017-11-13       Impact factor: 53.440

10.  Lithium targeting of AMPK protects against cisplatin-induced acute kidney injury by enhancing autophagy in renal proximal tubular epithelial cells.

Authors:  Hui Bao; Qianyun Zhang; Xinying Liu; Yaxiang Song; Xinhua Li; Zhen Wang; Changbin Li; Ai Peng; Rujun Gong
Journal:  FASEB J       Date:  2019-10-29       Impact factor: 5.191

View more
  5 in total

Review 1.  Immunometabolic rewiring of tubular epithelial cells in kidney disease.

Authors:  Sanne van der Rijt; Jaklien C Leemans; Sandrine Florquin; Riekelt H Houtkooper; Alessandra Tammaro
Journal:  Nat Rev Nephrol       Date:  2022-07-07       Impact factor: 42.439

2.  Menthol Targeting AMPK Alleviates the Inflammatory Response of Bovine Mammary Epithelial Cells and Restores the Synthesis of Milk Fat and Milk Protein.

Authors:  Songqi Liu; Wenjin Guo; Yuxi Jia; Bojian Ye; Shu Liu; Shoupeng Fu; Juxiong Liu; Guiqiu Hu
Journal:  Front Immunol       Date:  2021-12-22       Impact factor: 7.561

3.  Caspase-1 Inhibitor Reduces Pyroptosis Induced by Brain Death in Kidney.

Authors:  Weifeng Liu; Dongjing Yang; Jihua Shi; Peihao Wen; Jiakai Zhang; Zhihui Wang; Bowen Hu; Xiaoyi Shi; Shengli Cao; Wenzhi Guo; Shuijun Zhang
Journal:  Front Surg       Date:  2021-11-26

Review 4.  Fatty Acid β-Oxidation in Kidney Diseases: Perspectives on Pathophysiological Mechanisms and Therapeutic Opportunities.

Authors:  Zhumei Gao; Xiangmei Chen
Journal:  Front Pharmacol       Date:  2022-04-20       Impact factor: 5.988

Review 5.  Molecular mechanisms and physiological functions of autophagy in kidney diseases.

Authors:  Jingchao Yang; Longhui Yuan; Fei Liu; Lan Li; Jingping Liu; Younan Chen; Yanrong Lu; Yujia Yuan
Journal:  Front Pharmacol       Date:  2022-08-11       Impact factor: 5.988

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.